Header Logo

Connection

MICHAEL FRUMOVITZ to Uterine Cervical Neoplasms

Back to Details
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Uterine Cervical Neoplasms.
MICHAEL FRUMOVITZ
Connection Strength
15.778
Uterine Cervical Neoplasms
  1. PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
    View in: PubMed
    Score: 0.412
  2. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer. 2023 09 04; 33(9):1359-1369.
    View in: PubMed
    Score: 0.407
  3. Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist. 2023 07 05; 28(7):618-623.
    View in: PubMed
    Score: 0.402
  4. Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix. Int J Gynecol Cancer. 2023 04 03; 33(4):623-627.
    View in: PubMed
    Score: 0.395
  5. Open radical hysterectomy: The new standard of care in early-stage cervical cancer. BJOG. 2023 07; 130(8):851-855.
    View in: PubMed
    Score: 0.392
  6. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol Oncol. 2023 03; 170:328-332.
    View in: PubMed
    Score: 0.391
  7. RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. J Gynecol Oncol. 2023 07; 34(4):e50.
    View in: PubMed
    Score: 0.391
  8. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am J Obstet Gynecol. 2023 04; 228(4):445.e1-445.e8.
    View in: PubMed
    Score: 0.387
  9. Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2022 11 07; 32(11):1469-1474.
    View in: PubMed
    Score: 0.384
  10. Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study. Gynecol Oncol. 2022 06; 165(3):530-537.
    View in: PubMed
    Score: 0.369
  11. Early-stage, high-grade neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2021 08; 31(8):1179-1183.
    View in: PubMed
    Score: 0.352
  12. Surgical staging, the meaning of life, and other existential ponderings. Int J Gynecol Cancer. 2020 12; 30(12):1862-1863.
    View in: PubMed
    Score: 0.336
  13. Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix. Int J Gynecol Cancer. 2020 09; 30(9):1303-1307.
    View in: PubMed
    Score: 0.328
  14. Comparative genomics of high grade neuroendocrine carcinoma of the cervix. PLoS One. 2020; 15(6):e0234505.
    View in: PubMed
    Score: 0.326
  15. Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol. 2020 09; 158(3):570-575.
    View in: PubMed
    Score: 0.325
  16. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020 06; 21(6):851-860.
    View in: PubMed
    Score: 0.325
  17. International Gynecologic Cancer Society 2019 meeting summary. Int J Gynecol Cancer. 2020 02; 30(2):167-173.
    View in: PubMed
    Score: 0.317
  18. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer. 2019 07; 29(6):986-995.
    View in: PubMed
    Score: 0.305
  19. Reproductive counseling and pregnancy outcomes after radical trachelectomy for early stage cervical cancer. J Gynecol Oncol. 2019 May; 30(3):e45.
    View in: PubMed
    Score: 0.301
  20. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018 10; 19(10):1394-1403.
    View in: PubMed
    Score: 0.287
  21. Radical Hysterectomy and Age: Outcomes Comparison Based on a Minimally Invasive vs an Open Approach. J Minim Invasive Gynecol. 2018 Nov - Dec; 25(7):1224-1230.
    View in: PubMed
    Score: 0.278
  22. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
    View in: PubMed
    Score: 0.258
  23. Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take? Gynecol Oncol. 2017 01; 144(1):3-4.
    View in: PubMed
    Score: 0.256
  24. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2017 Jan; 144(1):46-50.
    View in: PubMed
    Score: 0.254
  25. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557.
    View in: PubMed
    Score: 0.251
  26. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer. Gynecol Oncol. 2016 08; 142(2):283-5.
    View in: PubMed
    Score: 0.246
  27. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol Oncol. 2016 06; 141(3):588-591.
    View in: PubMed
    Score: 0.244
  28. Small- and Large-Cell Neuroendocrine Cervical Cancer. Oncology (Williston Park). 2016 Jan; 30(1):70, 77-8, 93.
    View in: PubMed
    Score: 0.239
  29. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther. 2015; 15(7):805-10.
    View in: PubMed
    Score: 0.229
  30. Sentinel nodes in cervical cancer: surgical innovation outside the ivory towers. Ann Surg Oncol. 2015 Jun; 22(6):1759-60.
    View in: PubMed
    Score: 0.222
  31. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-1104.
    View in: PubMed
    Score: 0.222
  32. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5.
    View in: PubMed
    Score: 0.208
  33. Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53.
    View in: PubMed
    Score: 0.205
  34. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014 Jan-Feb; 21(1):3-8.
    View in: PubMed
    Score: 0.202
  35. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7.
    View in: PubMed
    Score: 0.190
  36. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.
    View in: PubMed
    Score: 0.189
  37. Utility of conization with frozen section for intraoperative triage prior to definitive hysterectomy. Gynecol Oncol. 2012 Nov; 127(2):307-11.
    View in: PubMed
    Score: 0.189
  38. Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol. 2012 Sep; 126(3):351-6.
    View in: PubMed
    Score: 0.186
  39. Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. Int J Gynecol Cancer. 2011 Jan; 21(1):123-7.
    View in: PubMed
    Score: 0.169
  40. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-99.
    View in: PubMed
    Score: 0.152
  41. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct; 112(4):899-905.
    View in: PubMed
    Score: 0.145
  42. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S17-20.
    View in: PubMed
    Score: 0.141
  43. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S25-8.
    View in: PubMed
    Score: 0.141
  44. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S21-4.
    View in: PubMed
    Score: 0.141
  45. Puntambekar et Al. Laparoscopic total radical hysterectomy by the Pune technique: our experience of 248 cases. J Minim Invasive Gynecol. 2008 Mar-Apr; 15(2):254-5; author reply 255.
    View in: PubMed
    Score: 0.139
  46. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol. 2007 Jul; 110(1):96-102.
    View in: PubMed
    Score: 0.133
  47. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol. 2006 Apr; 194(4):1186-93; discussion 1193-5.
    View in: PubMed
    Score: 0.122
  48. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.
    View in: PubMed
    Score: 0.118
  49. Quality of life in cervix cancer survivors--what matters the most in the long-term? Gynecol Oncol. 2005 May; 97(2):307-9.
    View in: PubMed
    Score: 0.114
  50. Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma. Gynecol Oncol. 2005 Jun; 97(3):942-5.
    View in: PubMed
    Score: 0.114
  51. Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer. Int J Gynecol Cancer. 2024 Dec 02; 34(12):1861-1866.
    View in: PubMed
    Score: 0.111
  52. LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. J Clin Oncol. 2024 Aug 10; 42(23):2741-2746.
    View in: PubMed
    Score: 0.107
  53. Consensus on surgical technique for sentinel lymph node dissection in cervical cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):504-509.
    View in: PubMed
    Score: 0.106
  54. Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study. Int J Gynecol Cancer. 2024 Feb 05; 34(2):209-215.
    View in: PubMed
    Score: 0.105
  55. Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical hysterectomy or trachelectomy. Int J Gynecol Cancer. 2024 Jan 05; 34(1):28-34.
    View in: PubMed
    Score: 0.104
  56. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. Int J Gynecol Cancer. 2023 02 06; 33(2):293-298.
    View in: PubMed
    Score: 0.098
  57. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal. Gynecol Oncol. 2022 06; 165(3):642-649.
    View in: PubMed
    Score: 0.092
  58. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021 10; 31(10):1317-1325.
    View in: PubMed
    Score: 0.089
  59. Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. 2020 07 01; 6(7):1019-1027.
    View in: PubMed
    Score: 0.082
  60. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
    View in: PubMed
    Score: 0.081
  61. Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain. Int J Gynecol Cancer. 2020 06; 30(6):873-878.
    View in: PubMed
    Score: 0.080
  62. Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002). Gynecol Oncol. 2020 04; 157(1):161-166.
    View in: PubMed
    Score: 0.079
  63. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Am J Obstet Gynecol. 2020 03; 222(3):249.e1-249.e10.
    View in: PubMed
    Score: 0.078
  64. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol. 2019 06; 135:58-64.
    View in: PubMed
    Score: 0.075
  65. Imaging and staging of neuroendocrine cervical cancer. Abdom Radiol (NY). 2018 12; 43(12):3468-3478.
    View in: PubMed
    Score: 0.073
  66. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018 Nov 15; 379(20):1895-1904.
    View in: PubMed
    Score: 0.073
  67. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018; 9:2102.
    View in: PubMed
    Score: 0.072
  68. Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (=2?cm) cervical cancer: Bridging the gap to fetal viability. Gynecol Oncol. 2018 07; 150(1):50-55.
    View in: PubMed
    Score: 0.071
  69. Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete. Gynecol Oncol. 2018 06; 149(3):520-524.
    View in: PubMed
    Score: 0.069
  70. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018 01; 148(1):132-138.
    View in: PubMed
    Score: 0.068
  71. Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF). Gynecol Oncol. 2017 09; 146(3):676-677.
    View in: PubMed
    Score: 0.066
  72. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468.
    View in: PubMed
    Score: 0.065
  73. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553.
    View in: PubMed
    Score: 0.064
  74. Radical trachelectomy in early-stage cervical cancer: A comparison of laparotomy and minimally invasive surgery. Gynecol Oncol. 2015 Sep; 138(3):585-9.
    View in: PubMed
    Score: 0.058
  75. Radical Trachelectomy for Early-Stage Cervical Cancer: A Survey of the Society of Gynecologic Oncology and Gynecologic Oncology Fellows-in-Training. Int J Gynecol Cancer. 2015 May; 25(4):681-7.
    View in: PubMed
    Score: 0.057
  76. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol. 2015 Jan; 136(1):48-53.
    View in: PubMed
    Score: 0.055
  77. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer. 2014 Jul; 24(6):1077-84.
    View in: PubMed
    Score: 0.054
  78. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014 Jan; 132(1):254-9.
    View in: PubMed
    Score: 0.051
  79. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6.
    View in: PubMed
    Score: 0.049
  80. Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: a comparison between laparoscopy and robotic surgery. Ann Surg Oncol. 2013 Apr; 20(4):1355-9.
    View in: PubMed
    Score: 0.048
  81. Laparoscopic radical trachelectomy. JSLS. 2012 Jul-Sep; 16(3):503-7.
    View in: PubMed
    Score: 0.047
  82. Quality of laparoscopic radical hysterectomy in developing countries: a comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia. Gynecol Oncol. 2012 May; 125(2):326-9.
    View in: PubMed
    Score: 0.045
  83. Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gynecol Oncol. 2012 Feb; 124(2):276-80.
    View in: PubMed
    Score: 0.045
  84. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.
    View in: PubMed
    Score: 0.044
  85. Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 2011 Mar; 120(3):321-5.
    View in: PubMed
    Score: 0.043
  86. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 01; 117(9):1928-34.
    View in: PubMed
    Score: 0.042
  87. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5.
    View in: PubMed
    Score: 0.041
  88. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Gynecol Oncol. 2010 Nov; 119(2):183-6.
    View in: PubMed
    Score: 0.041
  89. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.
    View in: PubMed
    Score: 0.040
  90. Microscopic evaluation of lymph-node-bearing tissue in early-stage cervical cancer: a dual-institution review. Ann Surg Oncol. 2010 Apr; 17(4):1106-10.
    View in: PubMed
    Score: 0.039
  91. Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer. Gynecol Oncol. 2009 Jan; 112(1):110-3.
    View in: PubMed
    Score: 0.036
  92. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.
    View in: PubMed
    Score: 0.036
  93. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007 Dec; 107(3):458-63.
    View in: PubMed
    Score: 0.034
  94. Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol. 2007 Jul; 106(1):12-5.
    View in: PubMed
    Score: 0.033
  95. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol. 2007 May; 105(2):304-11.
    View in: PubMed
    Score: 0.032
  96. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.
    View in: PubMed
    Score: 0.032
  97. Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer. 2021 03; 31(3):339-344.
    View in: PubMed
    Score: 0.021
  98. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard? J Minim Invasive Gynecol. 2016 Feb 01; 23(2):186-93.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.